Small molecule inhibitors targeting the nuclease or ATPase activities of the UL15 protein exhibit unique mechanisms of action and potentially improved safety profiles, offering new strategies for the prevention and treatment of herpesvirus infections. Here, RPL27A is linked to Herpesviridae infectious disease.